Malignant Neoplasm of Stomach Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03228667QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced CancerTreatment
NCT03797326Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)Treatment
NCT02918162Perioperative Chemo and Pembrolizumab in Gastric CancerTreatment
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) CancerTreatment
NCT03342937KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric CancerTreatment